Asymmetry Capital Management, L.P. - Q4 2021 holdings

$188 Million is the total value of Asymmetry Capital Management, L.P.'s 24 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .

 Value Shares↓ Weighting
LRMR ExitLARIMAR THERAPEUTICS INC$0-34,943
-100.0%
-0.24%
GMTX ExitGEMINI THERAPEUTICS$0-284,079
-100.0%
-0.69%
ExitAVALO THERAPEUTICS INC$0-534,621
-100.0%
-0.70%
RNA ExitAVIDITY BIOSCIENCES INC$0-126,116
-100.0%
-1.87%
BAX ExitBAXTER INTERNATIONAL INC$0-61,570
-100.0%
-2.98%
KYMR ExitKYMERA THERAPEUTICS INC$0-89,071
-100.0%
-3.14%
AZN ExitASTRAZENECA PLC-SPONS ADRadr$0-116,242
-100.0%
-4.20%
PTCT ExitPTC THERAPEUTICS INC$0-215,985
-100.0%
-4.83%
ARNA ExitARENA PHARMACEUTICALS INC$0-150,001
-100.0%
-5.37%
SAGE ExitSAGE THERAPEUTICS INC$0-229,117
-100.0%
-6.10%
HOLX ExitHOLOGIC INC$0-138,884
-100.0%
-6.16%
PODD ExitINSULET CORP$0-36,732
-100.0%
-6.28%
MDT ExitMEDTRONIC PLC$0-83,737
-100.0%
-6.31%
ALKS ExitALKERMES PLC$0-373,382
-100.0%
-6.92%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-01-19
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CENTENE CORP21Q4 202110.7%
UNITEDHEALTH GROUP INC21Q4 20217.2%
AMICUS THERAPEUTICS INC20Q4 20218.0%
PTC THERAPEUTICS INC19Q3 202113.8%
AERIE PHARMACEUTICALS INC16Q4 20199.9%
JAZZ PHARMACEUTICALS PLC15Q2 202110.2%
BIO-RAD LABRATORIES13Q2 20216.3%
NEVRO CORP12Q3 20187.2%
NEUROCRINE BIOSCIENCES INC12Q4 20186.5%
NUCANA PLC-ADR12Q4 20202.6%

View Asymmetry Capital Management, L.P.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2022-01-19
13F-HR2021-11-04
13F-HR2021-07-28
13F-HR2021-05-11
13F-HR2021-02-11
13F-HR2020-11-12
13F-HR2020-08-06
13F-HR2020-05-13
13F-HR2020-02-12
13F-HR2019-11-12

View Asymmetry Capital Management, L.P.'s complete filings history.

Compare quarters

Export Asymmetry Capital Management, L.P.'s holdings